BOC-(S)-ALPHA-(2-TRIFLUOROMETHYL-BENZYL)-PROLINE
|
- $495.69 - $1647
- Product name: BOC-(S)-ALPHA-(2-TRIFLUOROMETHYL-BENZYL)-PROLINE
- CAS: 1217741-53-1
- MF: C18H22F3NO4
- MW: 373.37
- EINECS:
- MDL Number:MFCD06796796
- Synonyms:BOC-(S)-ALPHA-(2-TRIFLUOROMETHYL-BENZYL)-PROLINE;Boc-(S)-a-(2-trifluoromethylbenzyl)proline;(S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)-benzyl)pyrrolidine-2-carboxylic acid;(Tert-Butoxy)Carbonyl (S)-Alpha-(2-trifluoromethyl-benzyl)-Pro;(2S)-1-[(tert-butoxy)carbonyl]-2-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidine-2-carboxylic acid;N-(t-Butoxycarbonyl)-2-(2-trifluoromethylbenzyl)-D-proline;1,2-Pyrrolidinedicarboxylic acid, 2-[[2-(trifluoromethyl)phenyl]methyl]-, 1-(1,1-dimethylethyl) ester, (2S)-
7 prices
Selected condition：
Brand
- Alichem
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 5MG
- 250mg
- 1g
- ManufacturerAlichem
- Product number1217741531
- Product description(S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)benzyl)pyrrolidine-2-carboxylicacid
- Packaging1g
- Price$640.56
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAAA0010994
- Product description(S)-1-(TERT-BUTOXYCARBONYL)-2-(2-(TRIFLUOROMETHYL)BENZYL)PYRROLIDINE-2-CARBOXYLIC ACID 95.00%
- Packaging5MG
- Price$495.69
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAAA0010994
- Product description(S)-1-(TERT-BUTOXYCARBONYL)-2-(2-(TRIFLUOROMETHYL)BENZYL)PYRROLIDINE-2-CARBOXYLIC ACID 95.00%
- Packaging1G
- Price$1575
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM198338
- Product description(S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)-benzyl)pyrrolidine-2-carboxylicacid 95%
- Packaging1g
- Price$729
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21017344
- Product description(S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)benzyl)pyrrolidine-2-carboxylicacid 95+%
- Packaging1g
- Price$772
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number100387
- Product description(S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)-benzyl)pyrrolidine-2-carboxylic acid 95+%
- Packaging250mg
- Price$742
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number100387
- Product description(S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)-benzyl)pyrrolidine-2-carboxylic acid 95+%
- Packaging1g
- Price$1647
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Alichem | 1217741531 | (S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)benzyl)pyrrolidine-2-carboxylicacid | 1g | $640.56 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | AAA0010994 | (S)-1-(TERT-BUTOXYCARBONYL)-2-(2-(TRIFLUOROMETHYL)BENZYL)PYRROLIDINE-2-CARBOXYLIC ACID 95.00% | 5MG | $495.69 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | AAA0010994 | (S)-1-(TERT-BUTOXYCARBONYL)-2-(2-(TRIFLUOROMETHYL)BENZYL)PYRROLIDINE-2-CARBOXYLIC ACID 95.00% | 1G | $1575 | 2021-12-16 | Buy |
| Chemenu | CM198338 | (S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)-benzyl)pyrrolidine-2-carboxylicacid 95% | 1g | $729 | 2021-12-16 | Buy |
| Crysdot | CD21017344 | (S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)benzyl)pyrrolidine-2-carboxylicacid 95+% | 1g | $772 | 2021-12-16 | Buy |
| Matrix Scientific | 100387 | (S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)-benzyl)pyrrolidine-2-carboxylic acid 95+% | 250mg | $742 | 2021-12-16 | Buy |
| Matrix Scientific | 100387 | (S)-1-(tert-Butoxycarbonyl)-2-(2-(trifluoromethyl)-benzyl)pyrrolidine-2-carboxylic acid 95+% | 1g | $1647 | 2021-12-16 | Buy |
Properties
Boiling point :441.2±45.0 °C(Predicted)
Density :1.289±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :3.81±0.20(Predicted)
Density :1.289±0.06 g/cm3(Predicted)
storage temp. :2-8°C
pka :3.81±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|